GLYCOMIMETICS INC (GLYC) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Glycomimetics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Glycomimetics Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $598 K, a 12.4% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $598 K +$66.2 K +12.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $768 K +$16.7 K +2.22% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $955 K -$9.71 K -1.01% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.18 M +$8.79 K +0.75% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $532 K -$845 K -61.4% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $751 K -$825 K -52.3% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $965 K -$805 K -45.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.17 M -$786 K -40.1% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.38 M -$767 K -35.8% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $1.58 M -$749 K -32.2% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1.77 M -$731 K -29.2% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.96 M -$714 K -26.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.14 M -$697 K -24.5% Mar 31, 2021 10-Q 2021-05-03
Q4 2020 $2.33 M -$681 K -22.6% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $2.5 M -$665 K -21% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $2.67 M -$650 K -19.5% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $2.84 M -$635 K -18.3% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $3.01 M -$594 K -16.5% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $3.17 M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.32 M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $3.48 M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $3.6 M Jan 1, 2019 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.